Literature DB >> 10997611

The adipose tissue metabolism: role of testosterone and dehydroepiandrosterone.

G De Pergola1.   

Abstract

Testosterone (T) and dehydroepiandrosterone (DHEA) are fat-reducing hormones, even though they exert this effect by different mechanisms. In particular, T inhibits lipid uptake and lipoprotein-lipase (LDL) activity in adipocytes, and stimulates lipolysis by increasing the number of lipolytic beta-adrenergic receptors. An indirect sign of these effects is the decrease of adipocyte leptin production. Lastly, T inhibits differentiation of adipocyte precursor cells. Concerning DHEA, this hormone does not seen to have any of T effects; however, DHEA stimulates resting metabolic rate (RMR) and lipid oxidation, and enhances glucose disposal, by increasing the expression of GLUT-1 and GLUT-4 on fat cell plasma membrane. The insulin-like effect of DHEA would be associated to a decrease of plasma insulin concentrations and, thus, to an increase of the molar ratio between lipolytic hormones and insulin. Noteworthy, the fat-reducing effect of both T and DHEA seems to be more evident at the level of visceral adipose tissue.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10997611     DOI: 10.1038/sj.ijo.0801280

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  30 in total

Review 1.  Body composition changes with testosterone replacement therapy following spinal cord injury and aging: A mini review.

Authors:  Tom E Nightingale; Pamela Moore; Joshua Harman; Refka Khalil; Ranjodh S Gill; Teodoro Castillo; Robert A Adler; Ashraf S Gorgey
Journal:  J Spinal Cord Med       Date:  2017-08-03       Impact factor: 1.985

Review 2.  Interactions of metabolic hormones, adipose tissue and exercise.

Authors:  Robert G McMurray; Anthony C Hackney
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

3.  The endeavor of high maintenance homeostasis: resting metabolic rate and the legacy of longevity.

Authors:  Carmelinda Ruggiero; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-05       Impact factor: 6.053

4.  Low total testosterone levels are associated with the metabolic syndrome in elderly men: the role of body weight, lipids, insulin resistance, and inflammation; the Ikaria study.

Authors:  Christina Chrysohoou; Demosthenes Panagiotakos; Christos Pitsavos; Gerasimos Siasos; Evangelos Oikonomou; John Varlas; Athanasios Patialiakas; George Lazaros; Theodora Psaltopoulou; Marina Zaromitidou; Polina Kourkouti; Dimitris Tousoulis; Christodoulos Stefanadis
Journal:  Rev Diabet Stud       Date:  2013-05-10

5.  The effects of old, new and emerging medicines on metabolic aberrations in PCOS.

Authors:  Alexandra Bargiota; Evanthia Diamanti-Kandarakis
Journal:  Ther Adv Endocrinol Metab       Date:  2012-02       Impact factor: 3.565

6.  Testosterone and the metabolic syndrome.

Authors:  Vakkat Muraleedharan; T Hugh Jones
Journal:  Ther Adv Endocrinol Metab       Date:  2010-10       Impact factor: 3.565

Review 7.  Leptin as regulator of pulmonary immune responses: involvement in respiratory diseases.

Authors:  Juanita H J Vernooy; Niki D J Ubags; Guy G Brusselle; Jan Tavernier; Benjamin T Suratt; Guy F Joos; Emiel F M Wouters; Ken R Bracke
Journal:  Pulm Pharmacol Ther       Date:  2013-03-27       Impact factor: 3.410

8.  Erectile Dysfunction and Low Sex Drive in Men with Type 2 DM: The Potential Role of Diabetic Pharmacotherapy.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb
Journal:  J Clin Diagn Res       Date:  2016-12-01

Review 9.  Cellular and molecular mechanisms responsible for the action of testosterone on human skeletal muscle. A basis for illegal performance enhancement.

Authors:  F Kadi
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

10.  Effect of oral anabolic steroid on muscle strength and muscle growth in hemodialysis patients.

Authors:  Ouppatham Supasyndh; Bancha Satirapoj; Pornanong Aramwit; Duangkamol Viroonudomphol; Amnart Chaiprasert; Vipa Thanachatwej; Supat Vanichakarn; Joel D Kopple
Journal:  Clin J Am Soc Nephrol       Date:  2012-11-02       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.